Cetera Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | $9.56M | Buy |
16,453
+6,327
| +62% | +$3.68M | 0.08% | 261 |
|
2023
Q4 | $5.37M | Buy |
10,126
+714
| +8% | +$379K | 0.07% | 253 |
|
2023
Q3 | $4.76M | Buy |
9,412
+309
| +3% | +$156K | 0.07% | 257 |
|
2023
Q2 | $4.75M | Sell |
9,103
-476
| -5% | -$248K | 0.07% | 248 |
|
2023
Q1 | $5.52M | Buy |
9,579
+262
| +3% | +$151K | 0.09% | 230 |
|
2022
Q4 | $5.13M | Buy |
9,317
+2,723
| +41% | +$1.5M | 0.09% | 228 |
|
2022
Q3 | $3.34M | Buy |
6,594
+280
| +4% | +$142K | 0.09% | 244 |
|
2022
Q2 | $3.43M | Buy |
6,314
+941
| +18% | +$511K | 0.08% | 264 |
|
2022
Q1 | $3.17M | Sell |
5,373
-35
| -0.6% | -$20.7K | 0.06% | 311 |
|
2021
Q4 | $3.61M | Sell |
5,408
-105
| -2% | -$70.1K | 0.07% | 270 |
|
2021
Q3 | $3.15M | Buy |
5,513
+151
| +3% | +$86.3K | 0.06% | 305 |
|
2021
Q2 | $2.71M | Buy |
5,362
+516
| +11% | +$260K | 0.06% | 299 |
|
2021
Q1 | $2.21M | Buy |
4,846
+334
| +7% | +$152K | 0.06% | 300 |
|
2020
Q4 | $2.1M | Buy |
4,512
+660
| +17% | +$307K | 0.07% | 266 |
|
2020
Q3 | $1.7M | Buy |
3,852
+469
| +14% | +$207K | 0.06% | 274 |
|
2020
Q2 | $1.23M | Buy |
3,383
+933
| +38% | +$338K | 0.05% | 315 |
|
2020
Q1 | $695K | Buy |
2,450
+975
| +66% | +$277K | 0.04% | 387 |
|
2019
Q4 | $478K | Buy |
1,475
+27
| +2% | +$8.75K | 0.02% | 580 |
|
2019
Q3 | $422K | Buy |
1,448
+67
| +5% | +$19.5K | 0.02% | 596 |
|
2019
Q2 | $404K | Buy |
1,381
+225
| +19% | +$65.8K | 0.02% | 619 |
|
2019
Q1 | $312K | Sell |
1,156
-183
| -14% | -$49.4K | 0.02% | 632 |
|
2018
Q4 | $299K | Buy |
1,339
+236
| +21% | +$52.7K | 0.02% | 627 |
|
2018
Q3 | $272K | Sell |
1,103
-3,423
| -76% | -$844K | 0.01% | 767 |
|
2018
Q2 | $934K | Buy |
4,526
+104
| +2% | +$21.5K | 0.05% | 339 |
|
2018
Q1 | $910K | Buy |
+4,422
| New | +$910K | 0.05% | 329 |
|
2017
Q2 | – | Sell |
-1,634
| Closed | -$254K | – | 856 |
|
2017
Q1 | $254K | Buy |
+1,634
| New | +$254K | 0.02% | 630 |
|